Institution: | 1. Insilico Medicine Hong Kong Ltd., Hong Kong, China;2. Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway;3. Insilico Medicine AI Ltd., Masdar City, United Arab Emirates;4. Insilico Medicine Shanghai Ltd., Shanghai, China;5. Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, Illinois, USA;6. Department of Surgery, University of Chicago, Chicago, Illinois, USA |